Track Record of Identifying Rare Wealth CreatorsTrack Record of Identifying Rare Wealth Creators

Weekly Quality Compounders Watchlist

Horizontal Bar Chart Titled Inventory Turnover Ratio Showing Yearly Values Fy20 28 Fy21 26 Fy22 22 Fy23 18 Fy24 14 Fy25 11 fy25 Bar in Green
Inventory Turnover Ratio: The Operational Efficiency Secret That Reveals Whether Indian Companies Are Building Wealth or Sitting on Dead Stock
March 30, 2026
Hero Banner with Title sold a Quality Stock Too Early and Subtitle Plus a 2x2 Color Grid Labeled Trader gray Compounder green Drift light Gray Speculator orange
Sold a Quality Stock Too Early? Why Buying It Back at a Higher Price Is the Smartest Move You Can Make — Lessons from Buffett, Lynch and Fisher
March 30, 2026
Show all
Hero Header with Title weekly Quality Compounders Watchlist and Subtitle on a Dark Blue Background Featuring a Four block Grid Trader gray Compounder green Drift light Gray Speculator orange

#image_title

⚠️ Anti-F&O Warning: SEBI data shows 90% of F&O traders lose money. F&O is gambling — not investing. Focus on quality businesses for long-term wealth creation. Stay away from tips and intraday trading.

This week’s watchlist features fundamentally strong Indian small & mid-cap businesses selected for their high ROCE, debt-free balance sheets, consistent earnings growth, and strong promoter conviction. Titan Biotech remains our #1 conviction pick — here are other quality names worth watching alongside it.


#1 TOP PICK
⭐ CONVICTION BUY

Titan Biotech Ltd

BSE: 524717 | Biochemicals & Fermentation | Small Cap

Current Price
₹458

Market Cap
₹1,892 Cr

ROCE
16.9%

ROE
15%

Promoter Holding
55.78%

Practitioner lineage
Figure 1. Practitioner lineage — Where this framework comes from (illustrative)
Debt Status
Almost Debt-Free ✓

📊 Stock Price CAGR (Multi-Year Compounder)

1 Year
310%
5 Year
61% p.a.
10 Year
49% p.a.

💰 Q3 FY26 Financial Performance

Revenue: ₹56.51 Cr | Net Profit: ₹8.53 Cr (↑ 94% YoY) — The business is accelerating. Fermentation-based biochemicals serving pharma, food, and agriculture sectors with dominant niche positioning.

🏆 Why It’s Our #1 Pick: Titan Biotech is the complete package — exceptional long-term compounding track record (49% CAGR over 10 years), accelerating profitability (+94% YoY), almost debt-free, strong promoter conviction, and a tiny market cap of just ₹1,892 Cr. This is precisely the kind of hidden gem that creates generational wealth. Our research on Titan Biotech has been shared with 23 top investors including Mohnish Pabrai.

#2 WATCHLIST

Jyoti Resins & Adhesives Ltd

BSE: 514448 | Adhesives & Sealants | Small Cap (₹887 Cr)

Price (Mar 27)
₹739
ROCE
50%
ROE (3Y avg)
44.8%
Profit CAGR (5Y)
56.4%
Debt
Debt-Free ✓
P/E
12.7x

Why Watch: India’s #2 wood adhesive brand (Euro 7000), targeting ₹500 Cr revenue by FY29. Exceptional 50% ROCE + debt-free + 56% profit CAGR. Trading at a 36% discount to peers at just 12.7x P/E. A classic quality compounder in a non-cyclical niche.

#3 WATCHLIST

Nesco Ltd

BSE: 505355 | Real Estate / Exhibition & Convention Centers | Small-Mid Cap

ROCE
22.4%
Debt
Debt-Free ✓
Business
MICE + IT Park

Why Watch: Owner-operator model with irreplaceable real estate assets (BEC Mumbai — India’s largest exhibition center). Debt-free with 22.4% ROCE. Direct beneficiary of India’s booming MICE (Meetings, Incentives, Conferences, Exhibitions) industry. Consistent cash generation with minimal capex requirements.

#4 WATCHLIST

Maharashtra Seamless Ltd

BSE: 500265 | Steel Pipes & Tubes | Mid Cap

Where Titan FY25 maps
Figure 2. Where Titan FY25 maps — Five-factor read on the framework
D/E Ratio
Zero ✓
Profit CAGR (3Y)
68.9%
Sector
Oil & Gas / Infra

Why Watch: Zero debt with a blistering 68.9% profit CAGR over 3 years. A key supplier of seamless tubes to oil & gas and power sectors — directly benefiting from India’s infrastructure and energy push. Strong balance sheet gives it pricing power and resilience through commodity cycles.

#5 WATCHLIST

Garuda Construction & Engineering Ltd

NSE: GARUDA | Infrastructure & Construction | Small Cap

ROCE
30%
Profit CAGR
118%
Debt
Negligible ✓
P/E
~21x

Why Watch: A newly listed construction gem (Oct 2024) with an exceptional 118% profit CAGR and 30% ROCE, significantly above the industry median of 18%. Negligible debt. Serves government infra and real estate projects. At 21x P/E, still reasonably priced for the quality of growth.

#6 WATCHLIST

Integrity Infrabuild Ltd

Micro Cap | Infrastructure | Piotroski Score: 7/9

Price
₹137
ROCE
29.8%
ROE
61.3%
Revenue Growth (QoQ)
+42.7%
P/E
15.8x
Market Cap
₹59 Cr

Why Watch: Ultra-micro-cap with explosive metrics — 61.3% ROE, 29.8% ROCE, 42.7% revenue growth, and a Piotroski score of 7/9 indicating strong financial health. At just ₹59 Cr market cap and 15.8x P/E, this is the kind of deeply undervalued name that rewards patient investors. High risk but extraordinary upside potential. Do thorough due diligence.


🎓 Learn to Find Your Own Multibaggers

Watch our complete investing course to master the art of identifying quality compounders — just like Titan Biotech.

▶ Watch Free Investing Course on YouTube

Curated by Manish Goel | multibaggershares.com

Disclaimer: This article is for educational purposes only and does not constitute financial advice. The author may hold positions in stocks mentioned. Always conduct your own research and consult a SEBI-registered financial advisor before making investment decisions. Stock market investments are subject to market risks. Past performance does not guarantee future returns.

author avatar
Manish Goel
Manish Goel is a Chartered Accountant and the Founder of Multibagger Securities Research & Advisory Pvt. Ltd. (SEBI Registered Investment Adviser, INA100007736). A full-time value investor since 2010, he has helped thousands of investors build long-term wealth through quality stock picking and disciplined fundamental analysis.
+91-7380122211